NuCana plc
NUC-3373
colorectal cancer
Date
TBD
Phase 1 readout · Date TBD estimated
What's at stake
Phase 1 trial results for NUC-3373 in colorectal cancer are due Date TBD. A clean hit validates the program; a miss can gap the stock down hard.
Primary source
· SEC 6-K
verified 12h ago
“We are currently evaluating optimal combinations and indications for potential further clinical studies of NUC-3373.”